iNtRON Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 11 shareholders own 20.59% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.8%	Seong-Jun Yoon	4,900,000	₩27.5b	0%	no data
2.6%	The Vanguard Group, Inc.	860,297	₩4.8b	0.02%	no data
1.27%	Kyung Yoon	420,184	₩2.4b	0%	no data
0.96%	Samsung Asset Management Company, Ltd.	318,144	₩1.8b	0%	0.01%
0.5%	Dimensional Fund Advisors LP	164,162	₩920.9m	0%	no data
0.25%	Sang-Hyun Kang	83,968	₩471.1m	0%	no data
0.094%	Jae-Koo Seol	31,053	₩174.2m	0%	no data
0.049%	State Street Global Advisors, Inc.	16,331	₩91.6m	3.55%	no data
0.024%	KOREITASSET Management Company Limited	8,000	₩44.9m	160,000%	0.24%
0.0094%	American Century Investment Management Inc	3,112	₩17.5m	0%	no data
0.008%	NH-Amundi Asset Management	2,636	₩14.8m	0%	no data